Submitted by dcc on Fri, 2021-01-15 09:23 Study Title: Phase I Trial of Methotrexate, Rituximab, Lenalidomide, and Nivolumab (NIVO-MR2) Induction Followed by Lenalidomide and Nivolumab Maintenance in Primary CNS LymphomaCIRB: Adult CIRB - Early Phase EmphasisLead Group: AllianceStatus: ActiveReview Status: Available to Open
